Nuon Raises $5 Million

Nuon Therapeutics Inc., a San Francisco-based developer of drugs for chronic inflammatory diseases like multiple sclerosis and rheumatoid arthritis, has raised $5 million in Series A funding from GBS Venture Partners of Australia. The company also named a new CEO: Rodney Pearlman, president and CEO of Saegis Pharmaceuticals until its acquisition this past January by Denmark's H. Lundbeck.